Stocks and Investing Stocks and Investing
Tue, January 17, 2023
[ 12:00 AM ] - United States, WOPRAI
Olivia Brayer Initiated (BMY) at Buy and Held Target at $95 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Sean Eastman Maintained (ACM) at Buy with Increased Target to $100 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Carletti Maintained (ACGL) at Buy with Increased Target to $70 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $157 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Adam Jonas Maintained (ABG) at Sell with Decreased Target to $128 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jake Roberge Initiated (ADBE) at Buy on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Colin Langan Maintained (ADNT) at Buy with Increased Target to $46 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Fish Maintained (ZM) at Hold with Decreased Target to $75 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
John Difucci Downgraded (ZS) to Hold on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Peter Levine Maintained (ZS) at Buy with Decreased Target to $200 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Scott Graham Downgraded (AOS) to Hold and Decreased Target to $65 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Fish Maintained (ANET) at Buy with Decreased Target to $155 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Adam Jonas Downgraded (AN) to Sell and Decreased Target to $96 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jay Sole Maintained (VFC) at Hold with Increased Target to $29 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Peterson Maintained (VEEV) at Buy with Decreased Target to $200 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Colin Langan Maintained (VC) at Sell with Increased Target to $102 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Sophie Karp Maintained (WEC) at Buy with Increased Target to $103 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Steve Valiquette Maintained (WELL) at Buy with Increased Target to $82 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Mullan Downgraded (WEN) to Hold and Held Target at $23 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jared Garber Maintained (WEN) at Hold with Increased Target to $25 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Lauren Silberman Maintained (WEN) at Hold with Increased Target to $24 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jake Bartlett Maintained (WEN) at Strong Buy with Increased Target to $28 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Clark Maintained (WAFD) at Hold with Increased Target to $37 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jeff Rulis Maintained (WAFD) at Strong Buy with Increased Target to $45 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Simeon Gutman Upgraded (W) to Hold on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
John Difucci Downgraded (WDAY) to Strong Sell on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Phillip Jungwirth Upgraded (VLO) to Buy and Increased Target to $160 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Lewis Maintained (VNO) at Strong Buy with Decreased Target to $27 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Edward Woo Initiated (VVOS) at Strong Buy and Held Target at $63 on, Jan 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Risinger Upgraded (VRTX) to Buy and Increased Target to $374 on, Jan 17th, 2023

David Risinger Upgraded (VRTX) to Buy and Increased Target to $374 on, Jan 17th, 2023


Published on 2024-10-28 00:56:07 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of SVB Leerink, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy and Increased Target from $265 to $374 on, Jan 17th, 2023.

David has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Held Target at $340 on, Monday, December 19th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $301 on, Tuesday, November 15th, 2022
  • Brian Skorney of "Baird" Maintained at Hold and Held Target at $280 on, Monday, October 31st, 2022
  • Paul Matteis of "Stifel" Maintained at Hold and Held Target at $289 on, Sunday, October 30th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $285 on, Friday, October 28th, 2022


These are the ratings of the 8 analyists that currently disagree with David

  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $340 on, Thursday, November 17th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $350 on, Friday, November 11th, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $442 on, Monday, October 31st, 2022
  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $330 on, Friday, October 28th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $313 on, Friday, October 28th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $335 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $327 on, Monday, October 24th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $337 on, Friday, October 21st, 2022

Contributing Sources